Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome

被引：24
|
作者：
Lardenoye, CWTA [1 ]
van Schooneveld, MJ [1 ]
Treffers, WF [1 ]
Rothova, A [1 ]
机构：
[1] Univ Utrecht Hosp, Dept Ophthalmol, FC Donders Inst, NL-3508 GA Utrecht, Netherlands
来源：
BRITISH JOURNAL OF OPHTHALMOLOGY | 1998年 / 82卷 / 09期
关键词：
D O I：
10.1136/bjo.82.9.1013
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Aims-To determine the effect of modified macular grid photocoagulation in patients with refractory macular oedema due to uveitis or cataract extraction. Methods-In this study 20 patients with macular oedema underwent modified macular grid laser photocoagulation and were followed by means of standardised examinations (day 0, months 2, 6, and 12) consisting of best corrected visual acuity and fluorescein angiography. Results-The mean visual acuity increased from 0.16 before to 0.3 after laser treatment (p=0.013), and fluorescein leakage was significantly reduced (p=0.005). Visual prognosis was influenced by duration of the uveitis, not by sex or age. Conclusion-Modified macular grid laser photocoagulation had a beneficial effect on macular oedema caused by uveitis or the Irvine-Gass syndrome. A prospective, randomised study is needed to determine the exact place of modified macular grid photocoagulation in the treatment of patients with inflammatory or postsurgical macular oedema.
引用
收藏
页码：1013 / 1016
页数：4
相关论文
共 50 条
  • [21] OUR EXPERIENCE IN THE TREATMENT OF THE IRVINE-GASS SYNDROME
    ARCINIEGAS, CA
    MOSQUEDA, FM
    OPHTHALMOLOGICA, 1982, 184 (01) : 21 - 25
  • [22] Isolated foveolar detachment in Irvine-Gass syndrome
    Greene, A. B.
    Del Priore, L. V.
    Iranmanesh, R.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (09) : 1210 - 1211
  • [23] Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome
    Mitropoulos, Panagiotis G.
    Chatziralli, Irini P.
    Peponis, Vasileios G.
    Drakos, Evangelos
    Parikakis, Efstratios A.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2015, 23 (03) : 225 - 231
  • [24] Very-late-onset-Irvine-Gass-SyndromVery late onset Irvine-Gass syndrome
    J. Jakob-Girbig
    L. Hahner
    D. Meller
    Der Ophthalmologe, 2021, 118 : 1267 - 1271
  • [25] Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome
    Mayer, Wolfgang J.
    Kurz, Stefanie
    Wolf, Armin
    Kook, Daniel
    Kreutzer, Thomas
    Kampik, Anselm
    Priglinger, Siegfried
    Haritoglou, Christos
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2015, 41 (09): : 1954 - 1961
  • [26] Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass Syndrome
    Williams, George A.
    Haller, Julia A.
    Kuppermann, Baruch D.
    Blumenkranz, Mark S.
    Weinberg, David V.
    Chou, Connie
    Whitcup, Scott M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (06) : 1048 - 1054
  • [27] Foveal central bouquet abnormalities in early cystoid macular edema from Central Retinal Vein Occlusion, Irvine-Gass syndrome, and Uveitis
    Lenis, Tamara Lee
    Au, Adrian
    Hou, Kirk Kohwa
    Sarraf, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [28] Intravitreal Injection of Dexamethasone Implant and Ranibizumab in Cystoid Macular Edema in the Course of Irvine-Gass Syndrome
    Fenicia, Vito
    Balestrieri, Marco
    Perdicchi, Andrea
    MauriziEnrici, Maurizio
    DelleFave, Martina
    Recupero, Santi Maria
    CASE REPORTS IN OPHTHALMOLOGY, 2014, 5 (02): : 243 - 248
  • [29] Current Management Options in Irvine-Gass Syndrome: A Systemized Review
    Orski, Michal
    Gawecki, Maciej
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [30] Intravitreal triamcinolone acetonide for treatment of patients with Irvine-Gass syndrome
    Boscia, F
    Dammacco, R
    Quaranta, G
    Ferrari, TM
    Sborgia, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U675 - U675
12345